These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1653590)

  • 1. The effects of protein malnutrition on the pathogenesis of murine cytomegalovirus disease.
    Teo HK; Price P; Papadimitriou JM
    Int J Exp Pathol; 1991 Feb; 72(1):67-82. PubMed ID: 1653590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis.
    Ritter JT; Tang-Feldman YJ; Lochhead GR; Estrada M; Lochhead S; Yu C; Ashton-Sager A; Tuteja D; Leutenegger C; Pomeroy C
    Cardiovasc Pathol; 2010; 19(2):83-93. PubMed ID: 19217318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of natural killer cells in murine cytomegalovirus eye infection.
    Inoue Y; Minasi P; Oh JO
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):1954-62. PubMed ID: 8387975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.
    Reynolds RP; Rahija RJ; Schenkman DI; Richter CB
    Lab Anim Sci; 1993 Aug; 43(4):291-5. PubMed ID: 8231084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.
    Lenzo JC; Fairweather D; Cull V; Shellam GR; James Lawson CM
    J Mol Cell Cardiol; 2002 Jun; 34(6):629-40. PubMed ID: 12054850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
    Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
    J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immunocompetence by cyclosporin A, cyclophosphamide or protein malnutrition potentiates murine cytomegalovirus pneumonitis.
    Price P; Hopkins RM; Teo HK; Papadimitriou JM; Shellam GR
    Pathol Res Pract; 1991 Dec; 187(8):993-1000. PubMed ID: 1665228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection.
    Leung WC; Hashimoto K; Umehara K; Hata J
    Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.
    Selgrade MK; Ahmed A; Sell KW; Gershwin ME; Steinberg AD
    J Immunol; 1976 May; 116(5):1459-65. PubMed ID: 178797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
    Zhan X; Lee M; Abenes G; Von Reis I; Kittinunvorakoon C; Ross-Macdonald P; Snyder M; Liu F
    Virology; 2000 Jan; 266(2):264-74. PubMed ID: 10639313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
    Sandford GR; Burns WH
    J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.
    Bancroft GJ; Shellam GR; Chalmer JE
    J Immunol; 1981 Mar; 126(3):988-94. PubMed ID: 6257788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
    Lawson CM; O'Donoghue HL; Reed WD
    Immunology; 1992 Mar; 75(3):513-9. PubMed ID: 1315309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.